Purchase Order 75N91018P00660

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. valued at $12,500 on May 30, 2018, with ultimate completion by June 4, 2019. Work is performed in Bethesda, Maryland. The order covers genomic analysis instruments, consumables, or bioinformatics software under firm fixed price terms with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,554.00 on August 22, 2017, with a completion date of September 21, 2017. The order covers laboratory supplies, with place of performance in Pleasanton, California. Pricing is firm fixed price under a no-set-aside simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 15, 2018, with ultimate completion on April 13, 2018. The order covers laboratory supplies under firm fixed price terms. Place of performance is Pleasanton, California.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. for $22,366.00 in lab supplies, awarded August 15, 2017, with completion by September 13, 2017. Performance occurs at 10X Genomics' facility in Pleasanton, California. The order is firm fixed price with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on July 11, 2018. Work is performed in Pleasanton, California. The order carries no set-aside designation and is priced on a firm fixed price basis. Ultimate completion is scheduled for July 10, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc., for drugs and biologicals valued at $21,896.00, effective September 3, 2019, with final completion on September 30, 2019. Place of performance is Pleasanton, California. The order carries no small business set-aside and uses firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $10,718.00 on June 25, 2020, with completion scheduled for July 24, 2020. Performance takes place in Pleasanton, California. The order is firm fixed price with no set-aside designation. The source does not specify the items or services being procured.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for lab supplies valued at $5,847.00 on January 4, 2018, with completion targeted for February 2, 2018. Performance occurs in Pleasanton, California. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $5,600 on November 16, 2017, for laboratory supplies. Performance location is Pleasanton, California. The order carries a firm fixed price and ultimate completion date of December 31, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 6, 2018, for a maintenance agreement, with completion by April 4, 2018. Performance occurs in Pleasanton, California. The order is a firm fixed price acquisition with no set-aside applied.</p>